Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. V
4. SPY
5. PYPL
6. KLAC
7. SWKS
8. F
9. STX
10. CSGP

Go back to Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
(NASDAQ: LEXX) Delayed: 0.53 -0.01 (1.85%)
Previous Close $0.54    52 Week High $ 
Open $0.54    52 Week Low $ 
Day High $0.56    P/E N/A 
Day Low $0.51    EPS $ 
Volume 76,292